[1] |
WANG Chaoyi, SONG Qiang, XIONG Xin, WANG Mengyuan.
Research progress on diagnosis and treatment of granulomatous lobular mastitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 910-917.
|
[2] |
HU Kangyi, CAO Linzhong, WAN Chaochao, SHANG Zhengya, YANG Xiaorui, ZHANG Yongjie.
Research progress of traditional Chinese medicine regulating mitochondrial function in the treatment of steroid-induced femoral head necrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 688-696.
|
[3] |
ZHANG Mingkang, MA Yanrong, JIN Yongwen, ZHOU Yan, CUI Ruirui, WU Xin'an.
Advances in clinical research on drug-induced acute interstitial nephritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 419-428.
|
[4] |
BAI Jia, YANG Hong, LI Lingling, ZHANG Yangyang, YANG Ying, LV Haihong.
Study on the effect of vitamin D on diabetic neuropathy through mitochondrial/autophagy pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 214-219.
|
[5] |
HUANG Huizhen, HAN Lei, LIN Xiaodong, CHEN Lei.
Research progress on signal pathways related to the pathogenesis of pancreatitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 109-113.
|
[6] |
ZHANG Li, WANG Jin, LI Huizi, PENG Hui, HE Jun, PENG Shuangqing, GUO Jiabin.
Role of Nrf2 pathway in flutamide-induced mitochondrial biogenesis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 498-504.
|
[7] |
LIU Yizhen, REN Lingxuan, YANG Jianjun, HE Jianyu, LIU Xiaojun, WANG Long, LIN Rong.
Study on the screening of active constituents of Taohong Siwu Decoction and the protective effect of ferulic acid on myocardial injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 505-515.
|
[8] |
QUAN Haiyan, JIANG Xing, HE Lu.
Recent progress of mitophagy in hepatic insulin resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 198-204.
|
[9] |
MENG Shi, WANG Zhongqun.
Research progress on human immunodeficiency virus-associated pulmonary arterial hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1431-1440.
|
[10] |
WANG Xiaolin, GAO Pan, ZOU Yunzeng.
Association between mitochondrial oxidative stress and diabetic cardiomyopathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1080-1085.
|
[11] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
[12] |
DING Xueming, CHEN Tianpeng, XU Qiang, HE Huan, HE Ming.
Tetramethylpyrazine attenuates doxorubicin induced cardiotoxicity through 14-3-3γ/Bcl-2
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 361-367.
|
[13] |
ZHANG Pinghu, ZHANG Ling, LIU Changxiao.
Research progress of mitochondrial toxicity evaluation model for nucleoside drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1059-1065.
|
[14] |
ZHOU Yiwen, PING Yi.
Research progress on the mechanism and treatment of pelvic organ prolapse
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 595-600.
|
[15] |
CHEN Yi, CAO Hua, CAI Lingfang, CHEN Ben, CHEN Mingkun.
Lidocaine inhibits the malignant proliferation, invasion and regulates the mitochondrial respiration of osteosarcoma MG-63 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 519-526.
|